Titlebook: Nonanticoagulant Actions of Glycosaminoglycans; Job Harenberg,Benito Casu Book 1996 Plenum Press, New York 1996 Alzheimer.Oligosaccharid.b

Electrolysis

割讓

savage

Kevin R. Holme,Weisheng Liang,Zicheng Yang,France Lapierre,Patrick N. Shaklee,Lun Lam diseases. High affinity folate-radioisotope conjugates have been developed for imaging pathogenic FR-positive diseases, including cancer. Since the FR transports folates via a low capacity but high affinity endocytic pathway, a variety of FR-targeted antifolate drugs and folate conjugates bearing a

截?cái)?/a>

Roger A. Laine diseases. High affinity folate-radioisotope conjugates have been developed for imaging pathogenic FR-positive diseases, including cancer. Since the FR transports folates via a low capacity but high affinity endocytic pathway, a variety of FR-targeted antifolate drugs and folate conjugates bearing a

褪色

招人嫉妒

Blatant

Intact Biological Activity and Binding to Granulocytes of LMM-Heparin-Tyramine-Fitc, 5). This technique should provide an intact binding site of the LMM-Heparin to the binding sequences on proteins. Beside the anticoagulant activity, many non-anticoagulant activities of heparin are of clinical relevance (6). These may be induced by the binding of heparin to the endothelium, erythro

鴕鳥

A Detailed Evaluation of the Structural and Biological Effects of Alkaline O-Desulfation Reactions ree of polymerization). The well characterized pentasaccharide sequence responsible for the heparin-antithrobin III (ATIII) interaction,. and the minimal hexasaccharide sequence responsible for the heparin-bFGF interaction. are examples of interactions or activities of heparin mediated by specific o

航海太平洋

The Interaction of Basic Fibroblast Growth Factor (bFGF) With Heparan Sulfate Proteoglycans,ntracellular fate of bFGF, suggesting that bFGF-HSPGs complexes are involved in the intracellular delivery of bFGF. It derives that the bioavailability and the biological activity of bFGF strictly depend on the glycosaminoglycan milieu of the extracellular environment, indicating the possibility to

anchor

Binding of 125I-bFGF to Rat Aortic Smooth Muscle Cells,able results. The data presented are consistent with the concepts that: 1) specific structural features are involved in the interaction of SMC glycosaminoglycans with .I-bFGF, and 2) antimitogenic activity of heparin has structural requirements different than those for bFGF binding.